Targetable gene alterations such as EGFR, KRAS, ALK, ROS1, RAF1, RET, ERBB2, PIK3CA, MET, FGF, and potential targetable gene CBL were identified throughout tumor subtypes (Table 1). Here, ALK is linked to neoplasm.